Literature DB >> 32921911

Comparative evaluation of clinical outcome of indirect pulp treatment with calcium hydroxide, calcium silicate and Er,Cr:YSGG laser in permanent molars.

Arshad E1, Kumar Gyanendra1, Jatinder Kaur Dhillon1.   

Abstract

BACKGROUND: The aim of the study was to compare preservation of pulp vitality by indirect pulp treatment with calcium hydroxide, calcium silicate based cement (Biodentine) and Er,Cr:YSGG laser in permanent molars.
MATERIALS AND METHODS: 30 patients were selected for this study as per the inclusion and exclusion criteria in the age group of 6-14 years and then randomly allocated to three groups A, B & C. In group A, after caries excavation, calcium hydroxide (Dycal) was placed at the floor. In group B, after caries excavation, calcium silicate based cement (Biodentine) was placed at the floor. In group C, after caries excavation, decontamination of the cavity was done with Er,Cr:YSGG laser. This was followed by placement of permanent restorative material in all the groups. Clinical and radiographic success was monitored at 3, 6 and months. Data analysis was performed using Statistical Package for the Social Science-21 (SPSS-21).
RESULTS: At the end of 9 months, overall success rate of indirect pulp was 86.6%. There was no significant difference between the three groups. (p > 0.05).
CONCLUSION: The study showed that the success of indirect pulp treatment is independent of the type of liner used for pulp capping. Moreover, the study also shows that Er,Cr;YSGG laser can be effectively used for indirect pulp capping procedures. 2019, Japan Medical Laser Laboratory.

Entities:  

Year:  2019        PMID: 32921911      PMCID: PMC7456655          DOI: 10.5978/islsm.19-OR-09

Source DB:  PubMed          Journal:  Laser Ther        ISSN: 0898-5901


  28 in total

1.  Twenty-four-month clinical trial of visible-light-activated cavity liner in young permanent teeth.

Authors:  L H Straffon; R L Corpron; F W Bruner; F Daprai
Journal:  ASDC J Dent Child       Date:  1991 Mar-Apr

2.  Clinical and radiographic evaluation of indirect pulp treatment with MTA and calcium hydroxide in primary teeth (in-vivo study).

Authors:  Vimi George; Suresh Kumar Janardhanan; Balagopal Varma; Parvathy Kumaran; Arun Mamachan Xavier
Journal:  J Indian Soc Pedod Prev Dent       Date:  2015 Apr-Jun

3.  Biological response of pulps submitted to different capping materials.

Authors:  André Luiz Fraga Briso; Vanessa Rahal; Sandra Rahal Mestrener; Eloi Dezan Junior
Journal:  Braz Oral Res       Date:  2006 Jul-Sep

Review 4.  Formation of a hard tissue barrier after pulp cappings in humans. A systematic review.

Authors:  H Olsson; K Petersson; M Rohlin
Journal:  Int Endod J       Date:  2006-06       Impact factor: 5.264

5.  A practice-based study on stepwise excavation of deep carious lesions in permanent teeth: a 1-year follow-up study.

Authors:  L Bjørndal; A Thylstrup
Journal:  Community Dent Oral Epidemiol       Date:  1998-04       Impact factor: 3.383

6.  Hydration characteristics of Biodentine and Theracal used as pulp capping materials.

Authors:  Josette Camilleri
Journal:  Dent Mater       Date:  2014-04-29       Impact factor: 5.304

Review 7.  Critical appraisal of the literature on deep carious lesions.

Authors:  C Zerosi
Journal:  Int Dent J       Date:  1970-06       Impact factor: 2.512

8.  Indirect pulp capping: a bacteriologic study of deep carious dentine in human teeth.

Authors:  J B King; J J Crawford; R L Lindahl
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1965-11

9.  Biodentine(TM) induces TGF-β1 release from human pulp cells and early dental pulp mineralization.

Authors:  P Laurent; J Camps; I About
Journal:  Int Endod J       Date:  2011-12-22       Impact factor: 5.264

10.  Low-level laser therapy as an alternative for pulpotomy in human primary teeth.

Authors:  Nádia Carolina Teixeira Marques; Natalino Lourenço Neto; Camila de Oliveira Rodini; Ana Paula Fernandes; Vivien Thiemy Sakai; Maria Aparecida Andrade Moreira Machado; Thais Marchini Oliveira
Journal:  Lasers Med Sci       Date:  2014-09-21       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.